Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kun Karnchanapandh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Structure & Dynamics|April 26, 2023
Elucidation of bezlotoxumab binding specificity to toxin B in <i>Clostridioides difficile</i>Kun Karnchanapandh, Chonnikan Hanpaibool, Kamonpan Sanachai, et al.
Journal of Biomolecular Structure & Dynamics|March 21, 2024
Enhancing bezlotoxumab binding to <i>C. difficile</i> toxin B2: insights from computational simulations and mutational analyses for antibody designKun Karnchanapandh, Kamonpan Sanachai, Rungtiva P Poo-Arporn, et al.
ACS Omega|January 15, 2024
Corosolic Acid Induced Apoptosis via Upregulation of Bax/Bcl-2 Ratio and Caspase-3 Activation in Cholangiocarcinoma CellsOnanong Jedram, Pornpattra Maphanao, Kun Karnchanapandh, et al.
Pathology, Research and Practice|July 16, 2023
BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell linesHandy Riantana, Orawan Waenphimai, Panupong Mahalapbutr, et al.
Journal of Chemical Information and Modeling|June 15, 2026
LB-PaCS-MD Guided Simulations Reveal Transient Stabilization during TCR-pMHC DissociationKun Karnchanapandh, Phichayut Songpipat, Chonnikan Hanpaibool, et al.
ACS Omega|September 18, 2023
Discovery of Novel Naphthoquinone-Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular ModelingRonnakorn Leechaisit, Panupong Mahalapbutr, Pornthip Boonsri, et al.
European Journal of Medicinal Chemistry|January 29, 2025
Design, synthesis, and antiviral activity of fragmented-lapatinib aminoquinazoline analogs towards SARS-CoV-2 inhibitionAyomide Adediji, Akeanan Sroithongmoon, Aphinya Suroengrit, et al.
Biochemical Pharmacology|February 15, 2026
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptorsAndrea Blesio, Carmine Giorgio, Francesca Romana Ferrari, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Structure & Dynamics|April 26, 2023
Elucidation of bezlotoxumab binding specificity to toxin B in <i>Clostridioides difficile</i>Kun Karnchanapandh, Chonnikan Hanpaibool, Kamonpan Sanachai, et al.
Journal of Biomolecular Structure & Dynamics|March 21, 2024
Enhancing bezlotoxumab binding to <i>C. difficile</i> toxin B2: insights from computational simulations and mutational analyses for antibody designKun Karnchanapandh, Kamonpan Sanachai, Rungtiva P Poo-Arporn, et al.
ACS Omega|January 15, 2024
Corosolic Acid Induced Apoptosis via Upregulation of Bax/Bcl-2 Ratio and Caspase-3 Activation in Cholangiocarcinoma CellsOnanong Jedram, Pornpattra Maphanao, Kun Karnchanapandh, et al.
Pathology, Research and Practice|July 16, 2023
BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell linesHandy Riantana, Orawan Waenphimai, Panupong Mahalapbutr, et al.
Journal of Chemical Information and Modeling|June 15, 2026
LB-PaCS-MD Guided Simulations Reveal Transient Stabilization during TCR-pMHC DissociationKun Karnchanapandh, Phichayut Songpipat, Chonnikan Hanpaibool, et al.
ACS Omega|September 18, 2023
Discovery of Novel Naphthoquinone-Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular ModelingRonnakorn Leechaisit, Panupong Mahalapbutr, Pornthip Boonsri, et al.
European Journal of Medicinal Chemistry|January 29, 2025
Design, synthesis, and antiviral activity of fragmented-lapatinib aminoquinazoline analogs towards SARS-CoV-2 inhibitionAyomide Adediji, Akeanan Sroithongmoon, Aphinya Suroengrit, et al.
Biochemical Pharmacology|February 15, 2026
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptorsAndrea Blesio, Carmine Giorgio, Francesca Romana Ferrari, et al.
Pageof 1